Cite Filings / STLN / 9999999995-22-002827

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

Starling Oncology, Inc. Filed 2022-09-26 Acc 9999999995-22-002827

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2023-01-06 EFFECT Notice of Effectiveness
2022-09-26 EFFECT Notice of Effectiveness
2022-09-26 424B3 Prospectus
2022-09-26 SC 13D/A Beneficial Ownership Report
2022-09-26 4 10% owner sold 25,614 shares at an average $4.33 ($110,826)
2022-09-23 3 Initial Statement of Ownership
2022-06-03 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…